Quantitative analysis for Seaport Therapeutics, Inc. Common Stock (SPTX) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Unrated (50.0). 27 signals analyzed (23 differentiated alt-data).
SPTX stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-05-01 | $23.00 | $19.50 | $19.84 |
| 2026-05-13 | $16.70 | $15.57 | $16.50 |
| 2026-05-26 | $18.25 | $17.32 | $18.01 |
| 2026-06-05 | $18.31 | $16.35 | $16.44 |
| 2026-06-17 | $18.42 | $17.01 | $17.10 |
| 2026-06-30 | $22.98 | $21.04 | $21.72 |
| 2026-07-13 | $21.56 | $20.06 | $20.10 |
| 2026-07-23 | $22.53 | $21.16 | $21.94 |
| 2026-08-04 | $21.86 | $20.34 | $21.43 |
| 2026-08-17 | $25.07 | $23.52 | $24.40 |
| 2026-08-27 | $28.38 | $26.06 | $26.25 |
How Seaport Therapeutics, Inc. Common Stock stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| GDRX | GoodRx Holdings, Inc. | $874M | — |
| INMD | InMode Ltd. | $888M | 50.0 |
| ANRO | Alto Neuroscience, Inc. | $729M | — |
| CLYM | Climb Bio, Inc. | $717M | 43.0 |
View all Health Care stocks by valuation and signals →
Seaport Therapeutics, Inc. Common Stock (SPTX) scores Unrated (50.0), and the composite conceals a 42-point disagreement between its dimensions. It is strongest on technicals at 69, and weakest on competitive moat at 27. A stock can carry technicals that high while competitive moat sits at 27; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 69 |
| competitive moat | 27 |
StoQuant analyzes 27 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Seaport Therapeutics, Inc. Common Stock (SPTX): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/SPTX"><img src="https://stoquant.com/badge/SPTX.svg" alt="Seaport Therapeutics, Inc. Common Stock (SPTX) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.